While there have been significant advances in hemostatic products over the past 5-10 years, Luna is working to fill unmet needs that persist in the area of hemorrhage control.  Luna’s surgical hemostatic agent is currently under development and will be ideal for controlling hemorrhage during spinal surgery.  We have demonstrated adhesion and utility in both soft and hard tissues while providing a physical matrix to initiate clotting through the intrinsic pathway of the coagulation cascade.  Luna’s surgical hemostatic agent will be easy to use with an extended shelf-life and is made of abundant, low-cost, biologic-free, biocompatible and absorbable base material.